According to 180 Life Sciences's latest financial reports the company has a price-to-book ratio of -13.3.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | -16.8 | -1600.09% |
2022-12-31 | 1.12 | -66.9% |
2021-12-31 | 3.37 | 107.57% |
2020-12-31 | 1.63 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.81 | -121.13% | ๐บ๐ธ USA |